RVT-3101: "Statistically significant and clinically meaningful efficacy results observed at every dose tested and in both overall and biomarker positive populations"; Ulcerative colitis (41st Annual J.P. Morgan Healthcare Conference, Roivant Sciences) Jan 10, 2023
P2 data • Inflammatory Bowel Disease • Ulcerative Colitis
|